Metcela Inc., a clinical-stage biotech startup specializing in fibroblast-based cell therapy, has raised $12.7 million in Series B funding.
Company Info
Company
Metcela
Additional Info
Metcela Inc. is a pioneer biotechnology company founded in Japan. Metcela aims to be the first to commercialize biological products that heal damaged heart muscle to treat heart failure.
